⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMLX News
Amylyx Pharmaceuticals, Inc. Common Stock
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
businesswire.com
AMLX
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock
businesswire.com
AMLX
Form 8-K
sec.gov
AMLX
Form 8-K
sec.gov
AMLX
Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
businesswire.com
AMLX
Form 8-K
sec.gov
AMLX
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
AMLX
Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
businesswire.com
AMLX
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
businesswire.com
AMLX
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Amylyx Pharmaceuticals, Inc. – AMLX
globenewswire.com
AMLX